Novo Nordisk shares plummeted nearly 21% after the company cut its full-year sales and earnings outlook due to weak growth expectations for its Wegovy and Ozempic drugs in the U.S. The company also ...

AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the United States. Revenue climbed 12 percent to ...

European stocks rallied Tuesday, lifted by a slew of corporate earnings and as investors further assessed the impact of the EU-US trade agreement.US President Donald Trump's agreement with the ...